Why is "Drug development" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-13 09:39:44
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes preclinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug. The entire process—from concept through preclinical testing in the laboratory to clinical trial development, including Phase I–III trials—to approved vaccine or drug typically takes more than a decade.
Read more on Wikipedia →Related Topics
- Arzneimittelforschung
- Pre-clinical development
- Cost of drug development
- Amazon (company)
- Antiviral drug
- Attrition rate
- Bibcode (identifier)
- Biological activity
- Breakthrough Therapy
- C-Met inhibitors
Trending Topic Today
Search Interest Perspective
-
Taking the guesswork out of drug development for Chagas disease - Medical Xpress
-
HK inno.N, Atomatrix partner on AI-based obesity drug development - koreabiomed.com
-
Intellia heads to FDA after notching first late-stage win for in vivo gene editor - BioSpace
-
Veristat: Acquisition Of Certara’s Regulatory And Medical Writing Business Expands Capabilities Across Drug Development Lifecycle - Pulse 2.0
-
Researchers explore new approach to multi-virus drug development - Stanford University
-
This flower's toxic traits hold clues for safer drugs - Northeastern Global News
-
Insilico Medicine's AI Brain Tumor Drug Cuts Development Time to Six Months - 조선일보
-
Equal-Weight ETFs Are the Play for Small-Cap Drug Development. Here's How to Position Now - 24/7 Wall St.
-
FDA Reaches Key Goals for Reduction of Animal Testing in Drug Development - PharmTech.com
-
Merck inks $1 billion AI drug development deal with Google Cloud - TechTarget
-
Compass soars as Trump throws weight behind psychedelic drug development - FirstWord Pharma
-
Trump Executive Order Seeks to Accelerate Psychedelic Drug Development for PTSD, Addiction - Pharmacy Times
-
How India is closing the gap in global clinical drug development - theweek.in
-
Compass shares crash as ‘confounding’ survival data raise approvability questions for bispecific - BioSpace
-
[Exclusive] AI Drug Development Breakthrough: Achieving Both Efficacy and Productivity - 아시아경제
-
Penn researchers use AI to accelerate RNA drug development - The Daily Pennsylvanian
-
FDA Achieves Goals In Reducing Animal Testing In Drug Development - RTTNews
-
Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development - Reuters
-
Gene therapy leaders aim to help more Baby KJs with novel regulatory models - BioSpace
-
Lean Derisking: Smart Ways to Cross Drug Development’s “Valley of Death” - BioSpace
-
AI After Drug Development - asteriskmag.com
-
UVA researchers use AI to speed up drug development - WVIR
-
Four FDA Actions Reshaping Drug Development in 2026 - appliedclinicaltrialsonline.com
-
Insilico Medicine CEO on how best to use AI in drug development - statnews.com
-
Organoids as Predictive Translational Models for Drug Development - Genetic Engineering and Biotechnology News
-
Biomarker-Driven Strategies for Drug Development - Inside Precision Medicine
-
How wearable technology powers patient-focused drug development - Merck.com
-
Regulatory Agencies Establish Principles of Good AI Use in Drug Development - The ASCO Post
-
New paper urges caution as FDA plans to phase out animal testing in drug development - Illinois News Bureau
-
Pioneering drug development, one company at a time - YaleNews
-
FDA Outlines AI Principles for Drug Development - GovCIO Media & Research
-
Intracellular signaling proteins emerge as a key target in drug development - Medical Xpress
-
A driving force to accelerate drug development - ESMO Daily Reporter
-
Samsung Biologics targets early-stage drug development clients at AACR 2026 - koreabiomed.com
-
FDA and NIH announce more initiatives to reduce animal testing in drug development - statnews.com
-
Soligenix (NASDAQ: SNGX) Highlights Patient-Centric Drug Development Strategy Through Reformulation Approach - TipRanks
-
First locally discovered drug candidate: UAE joins AI-powered drug development race - ZAWYA
-
Insilico Medicine and Qilu Pharmaceutical Reach Near $120 Million Drug Development Collaboration to Accelerate Novel Cardiometabolic Therapies - Insilico Medicine
-
ASPR announces competition for antiviral drug development targeting certain viruses - American Hospital Association
-
FDA Proposes Speedy “Plausible Mechanism Framework” for Rare Disease Drug Development - the-scientist.com
-
Wearable technologies in clinical trials for drug development: trends and emerging opportunities - Nature
-
HanchorBio Selects Bloomberg to Strengthen its Strategic Intelligence Across Drug Development and Global Biopharma - The Manila Times
-
Neuropsychiatric drug development in China: Current status and emerging trends | Molecular Psychiatry - Nature
-
PDUFA: Essential to America’s edge in drug development and patient access - PhRMA
-
China Is Increasing Its Share of Global Drug Development - Goldman Sachs
-
Merck Commits Up to $1bn to Google Cloud AI Push, Targeting Faster Drug Development and Global Scale - Tekedia
-
Model Behavior: FDA and EMA’s Guide to Good AI in Drug Development - ArentFox Schiff
-
FDA Presses Forward on Patient-Focused Drug Development, Releases Final Guidance Focused on Fit-For-Purpose Clinical Outcome Assessments - Akin
-
FDA Proposes More Flexibility in Alternatives to Animal Testing in Drug Development - MedPage Today
-
From Awareness to Acceleration: Rare Disease Drug Development Enters a Pivotal Era - BioSpace
-
Failed experiment leads to surprise drug development breakthrough - Phys.org
-
Modulating the microbiome as an approach to anticancer drug development - PNAS
-
Analytical Solutions for Accelerating Peptide Drug Development - the-scientist.com
-
VSU Café Scientifique Focuses on Cancer Drug Development Nov. 21 - Valdosta State University
-
Centralized solutions help align drug development teams, providers, and patients - Wolters Kluwer
-
Lobe Sciences says White House order could aid brain disorder drug research - Stock Titan
-
Drug development for neglected diseases must account for kids - Nature
-
Expediting Drug Development in Japan: A PMDA Perspective - Wiley
-
Building the foundation for meaningful AI in drug development - Massachusetts Biotechnology Council
-
Realistic 3-D Colon Model Shifts Paradigm for Drug Development - New York Institute of Technology
-
A versatile toolkit for drug metabolism studies with GNPS2: from drug development to clinical monitoring - Nature
-
FDA and EMA release collaborative AI framework for drug development - Clinical Trials Arena
-
1,400 scientists from 65 countries joined this drug-modeling school - Stock Titan
-
FDA Advances Drug Development Innovation by Establishing ISTAND as Permanent Qualification Program - fda.gov
-
A Transformative Leap: Using AI Tools to Accelerate Clinical Drug Development and Pharmaceutical Trials - Old Dominion University
-
ImmunoForge to Accelerate CNS Drug Development with Innovative BBB Shuttle Platform 'LMT15' - The Manila Times
-
Model‐Informed Drug Development: Bang for the Buck? - Wiley
-
Exploiting Regulatory Loophole Speeds Cancer Drug Development - UCLA Anderson Review
-
The future of CNS drug development: signs of real progress - Drug Target Review
-
AI research targets faster drug development - uta.edu
-
How thermal analysis can enhance pharmaceutical drug development - europeanpharmaceuticalreview.com
-
FDA proposes to ease testing rules to speed up biosimilar drug development - Reuters
-
Unlocking the complexities of Drug Discovery & Development for prospective talent - Boehringer Ingelheim
-
Merck Partners With Google Cloud on AI Push in Drug Development - Digital Health News
-
BioMarin vets form Mendra to ‘modernize’ rare disease drug development - BioPharma Dive
-
Regulating the Use of AI in Drug Development: Legal Challenges and Compliance Strategies - Food and Drug Law Institute (FDLI)
-
Pharma Rewires Drug Development With AI Operations - PYMNTS.com
-
Opinion: Addressing the Regulatory Reality of Replacing In Vivo Models in Drug Development - BioSpace
-
Revolutionizing the Technology Behind Drug Development - Colby News
-
Big Tech and Big Pharma Build AI Factories for Drug Development - Seoul Economic Daily
-
“This Will Have a Negative Effect on the Entire Drug-Development Enterprise” - Harvard Medicine Magazine
-
US, European regulators set principles for 'good AI practice' in drug development - Reuters
-
OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI - Yahoo Finance
-
Data Back New Surrogate Endpoint to Accelerate AML Drug Development - Oncology News Central
-
Integrated Services for the Whole Drug Development Pathway - BioPharm International
-
Hengrui, BeOne top new analysis of Chinese drug development | STAT - statnews.com
-
Beyond animal models: how organoids could transform drug development - Nature
-
Inventing Miracles: How Patent Policy Shapes Drug Development - IPWatchdog.com
-
Genetic evidence informs the direction of therapeutic modulation in drug development - Nature
-
Modeling Drug Development Part 2: Post-Approval Development - American Enterprise Institute - AEI
-
FDA Provides Guidance To Prevent Returned Applications, Aid Patient-Focused Drug Development - BioSpace
-
Europe is not pulling its weight in paying for drug development, says Tomas Philipson - The Economist
-
Decision Inputs in Drug Development—Big Vs. Small Pharma: Is There a Difference? - appliedclinicaltrialsonline.com
-
Empowering Mid-size Pharma Companies with Integrated Drug Development, Regulatory Strategy, and AI Innovation - IQVIA
-
Drug development, patient access suffer under price controls - U.S. Chamber of Commerce
-
Queen Mary: improving the drug development pipeline - Queen Mary University of London
-
China's Innovent clinches new Lilly deal for immunology, cancer drug development - Reuters
-
Navigating the Meandering Path of Oncology Drug Development - American Association for Cancer Research (AACR)
-
CBO Report Finds Federal Cuts to NIH Would Threaten New Drug Development and Innovation - The ASCO Post
-
Lilly partners with Nvidia on AI supercomputer to speed up drug development - Reuters
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.